Philip Morris International Brings on Former Sanofi Exec as Chief Life Sciences Officer

Must Read

How To Block Your Bank Account And SIM Card In Case Of Emergency

Losing your phone and wallet or having them stolen can be very frustrating. However, in case that happens to...

List of United Bank for Africa (UBA) Sort Codes & Branches (with addresses) in Nigeria

The sort code is a number that usually identifies both the bank and the branch where an account is held. The sort...

List of Access Bank Sort Codes & Branches (with addresses) in Nigeria

The sort code is a number which usually identifies both the bank and the branch where an account is...
- Advertisement -

Jan. 11, 2021Philip Morris International Inc. (PMI) today announced the appointment of Jorge Insuasty to the position of Chief Life Sciences Officer, effective Jan. 15, 2021. Mr. Insuasty will report to the company’s CEO, André Calantzopoulos.

“Jorge’s wealth of experience across both the pharmaceutical and consumer healthcare industries makes him the ideal candidate to succeed John O’Mullane, who is retiring,” said Calantzopoulos.

“Jorge is a transformational leader in science and medicine and excels in driving product portfolio development through to market success. Science and a consumer-focused product portfolio are the cornerstones of our ambition to replace cigarettes with products that are a better choice than continued smoking. Jorge’s impressive track record will help ensure we reach our goals and take full advantage of adjacent revenue-generating opportunities.”

Mr. Insuasty joins PMI from Sanofi S.A., where most recently he was the Global Franchise Head of Immunology, Oncology, and Neurology for Sanofi Genzyme. During his nine-year tenure at Sanofi, he led the company’s product pipeline strategy, from candidate selection through the development and regulatory review processes, with a dozen novel drugs approved.

He orchestrated significant transformational change within the R&D and commercial functions to substantially increase speed and efficiency, fostered external collaboration and innovation, and was highly engaged with the investor community. Overall, he played a pivotal role in the turnaround of Sanofi’s R&D efforts.

Read Also:  Sanofi delivers strong 2019 business EPS growth of 6.8% at CER
- Advertisement -

Prior to Sanofi, Mr. Insuasty spent eight years at Novartis International AG as Global Head of Development, Neuroscience, and Ophthalmology. Before that, he was VP, Research and Development, Consumer Medicines at Bristol Myers Squibb. Mr. Insuasty holds an MD in cardiology from the University of Paris.

“I am very excited to join PMI,” said Insuasty. “The company’s transformation and smoke-free vision represent a tremendous public health opportunity and a business challenge, both of which I will be thrilled to contribute. And I also look forward to developing adjacent future growth drivers.”

This appointment follows the recent announcement that John O’Mullane, PMI’s current Chief Life Sciences Officer, will retire.

“We thank John for the enormous contributions he has made these last two years, driving innovation and rigour into our life sciences function, and we wish him well in his retirement,” added Calantzopoulos.

- Advertisement -

Philip Morris International (PMI) is leading a transformation in the tobacco industry to create a smoke-free future and ultimately replace cigarettes with smoke-free products to the benefit of adults who would otherwise continue to smoke, society, the company, and its shareholders.

- Advertisement -
Philip Morris International Brings on Former Sanofi Exec as Chief Life Sciences Officer - Brand SpurPhilip Morris International Brings on Former Sanofi Exec as Chief Life Sciences Officer - Brand Spur

Subscribe to BrandSpur Ng

Subscribe for latest updates. Signup to best of brands and business news, informed analysis and opinions among others that can propel you, your business or brand to greater heights.

- Advertisement -

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Philip Morris International Brings on Former Sanofi Exec as Chief Life Sciences Officer - Brand SpurPhilip Morris International Brings on Former Sanofi Exec as Chief Life Sciences Officer - Brand Spur

Latest News

Majority Optimistic About Tech in 2021, But Health, Jobs and Environment Top Personal Risk List

Geneva, Switzerland, 22 January 2021 — A new World Economic Forum/Ipsos survey found most adults are optimistic about accessing technology, digital...

Bears Dominated Proceedings in the Equities Market this Week

Equities market closed the week on a bearish note with selloffs witnessed across major tickers. The benchmark All Share Index (ASI) declined by 24bps...

Joeboy Announces Debut Album, ‘Somewhere Between Beauty & Magic’

Looks like Joeboy is going to be the first mainstream artist to drop an album this year. Joeboy has announced his debut album, Somewhere...

TNT Africa muscles up with exciting channel refresh for 2021

Modern and sleek logo, new wrestling show and fresh content on the cards… :  As of 1 February, TNT Africa, home of the best contemporary...

Sonnie Ayere Recognised As ECOWAS Icon Of Societal Development

22ND January, Lagos – The West Africa Youth Council has recognized Nigeria’s Sonnie Ayere as the winner of the ECOWAS Icon of Societal Development...
- Advertisement -
BrandsPur Weekly Cartoons
- Advertisement -Philip Morris International Brings on Former Sanofi Exec as Chief Life Sciences Officer - Brand SpurPhilip Morris International Brings on Former Sanofi Exec as Chief Life Sciences Officer - Brand Spur